Literature DB >> 669874

Pharmacokinetic investigations with 3H-penta-acetyl-gitoxin in volunteers and patients with respect to the occurrence of drug latentiation.

K O Haustein, C Pachaly, D Murawski.   

Abstract

After oral administration of 3H-penta-acetyl-gitoxin (Pengitoxin W.H.O., Pentagit) 1.5 mg to four volunteers, serum radioactivity diclines with a half-life of 62 +/- 10 hours. After an oral maintenance dose of 0.4 mg pengitoxin in five digitalized patients, four of them with a cannulated bile duct, serum radioactivity declines with half-life of 56 +/- 8 hours. In volunteers within 4 days 50.7% of the administered radioactivity is excreted in urine; in the patients 52.3% in urine and 28.0% in bile. By thin-layer chromatographic studies, 16-acetyl-gitoxin was charactrized as the main metabolite in serum, bile and urine. Furthermore, in the first 8 hours after administration, two additional metabolites occur in urine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669874

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  4 in total

1.  On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.

Authors:  K O Haustein; R G Alken; H J Lach; U Becker; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Investigation into the species-specific deacylation of penta-acetyl-gitoxin.

Authors:  K O Haustein; C Pachaly; R Megges; P Franke
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

3.  Measurement of plasma glycoside level following pengitoxin administration.

Authors:  K O Haustein
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

4.  On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.

Authors:  K O Haustein
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.